Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
4.995 USD | +5.27% | -2.36% | +11.10% |
Apr. 18 | Health Care Flat on Rotation From Rate-Sensitive Sectors -- Health Care Roundup | DJ |
Apr. 18 | Ocular Therapeutix Reports Positive Topline Data in Diabetic Retinopathy Trial; Shares Fall | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+11.10% | 734M | |
+26.20% | 661B | |
+27.23% | 566B | |
-6.33% | 352B | |
+20.69% | 332B | |
+3.66% | 283B | |
+14.21% | 231B | |
+5.15% | 200B | |
-8.96% | 195B | |
-4.71% | 145B |
- Stock Market
- Equities
- OCUL Stock
- News Ocular Therapeutix, Inc.
- JMP Securities Adjusts Ocular Therapeutix's Price Target to $24 From $12, Maintains Market Outperform Rating